Guidance on the Self-Monitoring of Blood Glucose in Adults with Diabetes

Similar documents
Guidance on the Self-Monitoring of Blood Glucose in Adults with Diabetes

DIABETES BLOOD GLUCOSE MONITORING AT HOME (ADULTS)

DIABETES BLOOD GLUCOSE MONITORING AT HOME (ADULTS)

DIABETES BLOOD GLUCOSE MONITORING AT HOME (ADULTS)

Walsall CCG Supported Blood Glucose Meters April 2018

Type 2 Diabetes Recommended SMBG

GUIDELINE FOR SELF MONITORING OF BLOOD GLUCOSE IN ADULTS WITH DIABETES

Guidance for the choice of blood glucose testing meters, strips and lancets

Monitoring in Type 2 Diabetes. Learning Outcomes. Type 2 Diabetes. Senga Hunter Community Diabetes Specialist Nurse

DATE RECEIVED 09/10/2017 SUBJECT Formulary PASSED TO Mary DATE PASSED 09/10/2017 RESPOND BY 27/10/2017 CATEGORY Business FoI NUMBER

Essential advice for people with diabetes from Accu-Chek. Time to test. G1812 Time to Test leaflet v5.indd 1 25/02/ :43

DIABETES: SAFE DRIVING AND THE DVLA

Initiating Injectables in Type 2 Diabetes. Tara Kadis Team Leader Diabetes Nurse Specialist York Teaching Hospital

the person is intolerant of either metformin or a sulphonylurea, or treatment with metformin or a sulphonylurea is contraindicated, and

Time to test. Do you do it enough? Essential advice for people with diabetes from Accu-Chek

Essential advice for people with diabetes from Accu-Chek. The inside story on diabetes

KEEPING SAFE WITH INSULIN THERAPY

Blood Glucose Test Strip Guidelines

PROCEDURE FOR BLOOD GLUCOSE MONITORING

home monitoring diary

Home Monitoring Diary

THE SHEFFIELD AREA PRESCRIBING GROUP. Position Statement for Prescribing of Freestyle Libre In Type 1 Diabetes. Date: March 2018.

EFFECTIVE SHARE CARE AGREEMENT. FOR THE off license use of GLP1 mimetics in combination with insulin IN DUDLEY

NHS Greater Glasgow and Clyde Adult Blood Glucose Meter and Test Strip Formulary

Placename CCG. Policies for the Commissioning of Healthcare

EXENATIDE (BYETTA ) PROTOCOL, 5mcg and 10mcg SC injection pre-filled pens

HOME HEALTH FOUNDATION CLINICAL TEAM COMPETENCY Clinical Bag Technique. EMPLOYEE STAFF POSITION Date

INFORMATION ON DRIVING AND DIABETES: GROUP 2 VEHICLES

DIABETES POLICY. Mandatory Quality Area 2

medicines_management/correspondence/pathway-for-the-managed- Access-of-FreeStyle-Libre.

This Diabetes Policy should be read in conjunction with the Dealing with Medical Conditions Policy of Goulburn Region Preschool Association Inc.

MANAGEMENT OF TYPE 2 DIABETES

Blood Glucose Testing

Optimising Insulin Pen Needles

NICE to. know... The facts you need to make the most of your diabetes care.

NHS GG&C Introduction of Freestyle Libre flash glucose monitoring system

Approval of Multiple Diabetes Management Products and Mesalazine proposals

Who is this booklet for?

Dept of Diabetes Main Desk

Placename CCG. Policies for the Commissioning of Healthcare

Urgent field safety notice

Injectable Therapies in Diabetes

TYPE 2 DIABETES SCREENING

Commissioning Statement

Guideline for antihyperglycaemic therapy in adults with type 2 diabetes

Injectable Therapies in Diabetes

Guideline on the Choice of Glucometers and Ketometers for ADULTS with TYPE 1 DIABETES (December 2018)

Managing your diabetes: Travel Advice

Policy for the Provision of Continuous Glucose Monitoring and Flash Glucose Monitoring to patients with Diabetes Mellitus

The inside story on diabetes

This Diabetes Policy should be read in conjunction with the Dealing with Medical Conditions Policy of Auburn South Preschool.

Urgent field safety notice

NHS Greater Glasgow and Clyde Adult Blood Glucose and Combined Ketone Meter and Test Strip Formulary

Commissioning Statement. Flash Glucose Monitoring system (FreeStyle Libre ) March 2018

June 2016 Review: June 2019

Continuous Subcutaneous Insulin Infusion (CSII) pump therapy

There have been important changes in diabetes care which may not be covered in undergraduate textbooks.

Accu-Chek Insight. Travelling & Holiday Guide. 3583_HolidayGuideA5booklet_Final.indd 1

Guideline on the Choice of Blood Glucose Meters, Ketone Meters and Test Strips for children and young people with. TYPE 1 DIABETES (November 2018)

In keeping with the Scottish Diabetes Group criteria, use should be restricted to those who:

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE GUIDANCE EXECUTIVE (GE)

THIS IS A PATIENT HAND HELD DOCUMENT CARE PATHWAY FOR MANAGEMENT OF INITIATION OF INSULIN

Policy for the Provision of Insulin Pumps for Patients with Diabetes Mellitus

Insulin Management. By Susan Henry Diabetes Specialist Nurse

Supporting Diabetes in the Workplace

Blood glucose monitoring and compatibility equipment checker

TYPE 2 DIABETES AND STEROID TABLETS

5.2 mmol USER GUIDE 5.2. Uses only CONTOUR NEXT blood glucose test strips from Bayer. Wireless Blood Glucose Monitoring System 12:00 PM METER BG

Injectable Therapies in Diabetes

NHS Leeds CCG. Policy for the Funding of Flash Glucose Monitoring (FlashGM) in Paediatrics and Adults

TYPE 2 DIABETES CRITERIA FOR REFERRAL TO LEVEL 2 OOHS

How they work and when to take them. Diabetes Medications

Blood Glucose monitoring during extra-corporeal renal therapy and plasmapheresis.

RDNS. Injection Therapy in injection therapy in diabetes. Type 2 Diabetes

Implementation of Freestyle Libre prescribing guidance across the NHS in London

Flash Glucose Monitoring (Flash GM) Frequently asked questions (November 2018)

North West London Diabetes Guidelines Helping healthcare practitioners manage adults with diabetes

TRAVEL. well as these emergencies, so it s a good idea to check your policy with your insurer before you go.

Management of Type 2 Diabetes

CHEMICAL REAGENTS 478 CHEMICAL REAGENTS. This document is dated 1 st March 2018

National Best Practice Guides: Inpatients on Continuous Subcutaneous Insulin Infusion (CSII)

INJECTABLE THERAPY FOR THE TREATMENT OF DIABETES

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE. Health Technology Appraisal

When and how to start insulin therapy in type 2 diabetes

ADVANCE PREPARATION OF INSULIN FOR PATIENTS TO ADMINISTER AT HOME

DIABETES POLICY. Templeton Primary School strives to ensure the safety and wellbeing of children who are diagnosed with diabetes, and committed to:

National Diabetes Inpatient Audit (NaDIA) 2016

HYDROXYBUTERATE) Gluco Rx Evolve KetoneTest Strips

NDLS. Diabetes and Driving

insulin initiation in type 2 diabetes

UNCOVERING THE BENEFITS OF THE ACCU- CHEK BOLUS ADVISOR MICHAEL PORTER CDE

The Wheel of Life Exercise. What s Happening? Where to start the beginning. What's in a meter- are they all the same?

PATIENT INFORMATION. When you are taking Suliqua

YOU HAVE DIABETES. Angie O Connor Community Diabetes Nurse Specialist 25th September 2013

exenatide 2mg powder and solvent for prolonged-release suspension for injection (Bydureon ) SMC No. (748/11) Eli Lilly and Company Limited

Transcription:

Introduction Guidance on the Self-Monitoring of Blood Glucose in Adults with Diabetes This guideline is designed to offer guidance for primary and secondary care on the use of selfmonitoring of blood glucose in patients with Type 2 diabetes mellitus. Type 2 Diabetes Routine self-monitoring of blood glucose is not required if patients are well controlled, and on non-insulin therapy that will not increase the risk of hypoglycaemia (including oral treatment, diet and exercise control). Patient education should clearly identify potential situations where hypo and hyperglycaemia may arise. Examples of these include: Any non-minor illness Concomitant systemic steroid therapy Initiation of a sulphonylurea/ insulin People with Type 2 diabetes usually have more stable glycaemic control and therefore advice on the frequency of testing will reflect this as well as the treatment they are on. In practice, the level of monitoring will vary according to the treatment regime in use and the target level of glycaemic control set for the patient, and driving requirements. Diet and exercise Metformin and/ or Pioglitazone, Gliptin/ Liraglutide/ Exenatide Sulphonylurea and/or other treatments Basal insulin and oral medication BD Pre-Mixed insulin Multiple daily injection (MDI) regimes HbA1c is the real outcome measure for these patients. Blood glucose monitoring should not be required routinely, but may be required: During illness When therapy is changed If steroids are co-prescribed (midday, before evening meal and 2 hours after evening meal) When regular HbA1c testing is not available Patients with postprandial hyperglycaemia Pre-conception care and pregnancy Terminal care/end of life patients BUT ONLY as part of a care plan These patients are at risk of hypos. Testing may be a useful guide for: Evaluating lifestyle changes New or increased treatment Where required for driving Fasting glucose can be used to titrate basal insulin dose and results and at other times to identify trends of hyper and hypoglycaemia Test at various times including before meals and at bed time. May be advised post prandial in specific circumstances Test at various times including before meals and at bed time. May be advised post prandial in specific circumstances 1

Driving The main issue in relation to driving and the law is the risk of hypoglycaemia. It is important that any patient who is using treatment(s) that can cause hypoglycaemia (insulin / sulphonylurea) has the means to test their blood glucose It is recommended that these patients test their blood glucose prior to driving, and at intervals (every 2 hours) during long journeys. Following hypoglycaemia and treatment to correct this, blood glucose must be in the normal range (above 5mmol/l) for 45 mins prior to resuming driving. There must be full hypo awareness at every episode For Group 2 and vocational licences, evidence is required of twice daily blood glucose testing and at times related to driving (no more than 30 mins before the start of the first journey and at two hourly intervals while driving). These patients must have a blood glucose meter with the facility to store a minimum of 3 months of results, which is reviewed annually by an appropriate medical professional. All meters in use must be reviewed. A meter with the facility to download results is recommended and all recommended meters in this guidance have this facility. Group 1 license holders must notify the DVLA if they have more than one episode of severe hypoglycaemia in the preceding 12 months Group 2 license holders must notify the DVLA if they have one episode of severe hypoglycaemia in the preceding 12 months More information on driving and diabetes can be found on the Diabetes UK and DVLA websites Alternative Site Testing These results must be used with caution in the following circumstances: When making frequent insulin dose adjustment decisions e.g. following new diagnosis During illness management Following exercise For hypoglycaemia management, especially if poor warning symptoms Lancers and Lancets Each meter (see later) is supplied with a lancer and will require lancets on prescription Lancers (the finger pricking devices) are not available on prescription Replacement Lancers are available from companies (usually free of charge) Lancets are for single use only Pen Needles for insulin injection devices The recommended pen needles for the majority of patients are GlucoRx FinePoint needles, available in a full range of lengths; 4mm, 5mm, 6mm, 8mm, and 10mm (12mm is also available if needed). BD viva pen needles are also available in the following lengths; 4mm, 5mm, 8mm and are recommended as an alternative pen needle. Where a safety needle is required to protect against needle stick injuries, the recommended pen needles are mylife Clickfine AutoProtect needles, available in 5mm and 8mm lengths. Safety needles are only recommended where insulin is administered 2

by a third party, eg District Nurse, Care Home, or where patient has genuine needle phobia. Both brands and are compatible with all leading insulin injection device manufacturers including Eli Lilly, Novo Nordisk AS and Sanofi. The advantages of standardising this choice are consistency and cost effectiveness. 3

Blood Glucose Meters and Testing Strips Blood glucose monitoring requires the use of appropriate equipment. The aim of this guidance is to limit the use of a wide variation of different blood glucose testing equipment across the locality. Advantages are; consistency, reduced risk of errors due to unfamiliarity with equipment, limited unnecessary prescribing, and cost effectiveness. Blood glucose testing should be used as part of a care plan for the management of diabetes following structured patient education which includes the purpose of testing The decision to change meters should be used as an opportunity to review the purpose of testing and the interpretation of results If a change in prescribed test is required, patients should be encouraged to use their current supply of test first, as long as the have not reached their expiry date and the current meter is in working order The majority of test expire within 90 days of opening. If one container usage is over a longer period than this, review of blood glucose monitoring needs is recommended Patients should be reminded to use control solutions/calibrate machines in line with manufacturer recommendations (as a minimum each time a new pot of test is commenced) All the chosen meters are compliant with DVLA guidance, although the fully integrated device may encourage greater testing in Group 2/ vocational drivers All the chosen meters meet ISO standards and do not require coding The recommended meters should meet the need for the majority of patients with Type 2 diabetes. There still remains the need for specialist services to prescribe and recommend meters and that offer the facility for more specialized/specific requirements. 4

Blood Glucose Meters and Testing Strips (Note for instructions on locating products on EMIS, please see appendix 1) 1 st Choice Meter suitable for the majority of patients: Performa Nano *existing patients may continue on accu-check active If not suitable to meet patient needs 2 nd Choice Meters: Contour Black Edition *useful for patients where a larger meter is required GlucoRx Nexus Voice *useful for visually impaired/eyesight problems If not suitable to meet patient needs 3 rd Choice Meter: Only for patients who require strip-free testing due to occupation/ job, especially to comply with DVLA guidelines for Group 2 and vocational drivers license holders. Mobile NB. These meters and should be suitable for the majority (~80%) of patients. There still remains the need for specialist services to prescribe and recommend meters and that offer the facility for more specialised/specific requirements. Details of the test and lancers required on prescription for each meter are included in the table below. 5

2 nd Choice - more specific requiremen t 1 st Choice meets the needs of the majority of patients Meter Name Test Benefits Lancets Cost* (50 ) Company Performa Nano Performa test - Small meter size - Easy to use - 5 second results - No sharps handling or disposal - 18 month test strip expiry (no difference to expiry once opened) - Large screen size glow in the dark display - No coding required - Downloadable data - 500 test memory FastClix Lancing drum 5.90 for 204 9.95 Roche Customer careline: 0800 701000 www.accu-chek.co.uk (NB specific site link for professionals) Bayer Contour Black Edition Bayer Contour test - 5 second results - Larger size meter - No coding required - 24 month test strip expiry once opened - 480 test memory - Downloadable data - Bayer Microlet lancets 3.90 for 100 7.44 for 200 9.95 Bayer (Now Ascensia diabetes care) Customer careline: 0345 600 6030 diabetessuport@asce nsia.com www.diabetes.ascensi a.co.uk = Approved by: Sunderland Diabetes Network & SCCG Medicines Optimisation and Guidelines Group December 2016 Review: December 2018

4 th choice select/ more specialised group of patients 2 nd Choice - more specific requirement s Meter Name Test Benefits Lancets Cost* (50 ) Company GlucoRx Voice* GlucoRx Nexus test - Talking meter for patients who are visually impaired - 5 second results - Downloadable data - 6 month expiry once opened GlucoRx lancets 5.50 for 200 9.95 GlucoRx Customer careline: 01483 755133 www.glucorx.co.uk info@glucorx.co.uk Mobile Mobile test cassettes - Strip free testing - Integrated lancing device - No sharps handling or disposal - Downloadable data - 5 second results - 90 days expiry once inserted into device FastClix Lancing drum 5.90 for 204 9.99 per cassette of 50 tests Roche Customer careline: 0800 701000 www.accu-chek.co.uk (NB specific site link for professionals) Approved by: Sunderland Diabetes Network & SCCG Medicines Optimisation and Guidelines Group December 2016 Review: December 2018

Appendix 1: Finding recommended blood glucose products on EMISweb Thanks to staff at Rickleton practice for sharing the below table for inclusion in this guideline Name of blood glucose meter Performa Nano Bayer Contour Black Edition Name of test strip Name on EMISweb Position on guideline Accu-check Performa test Performa testing 1 st choice (suitable from the majority of patients) Bayer Contour test Contour testing 2 nd choice (useful for patients where a larger meter is required) GlucoRx Voice GlucoRx Nexus test GlucoRx Nexus testing Mobile Mobile test cassettes Mobile cassette 2 nd choice (useful for visually impaired/eyesight problems) 3 rd choice (only for patients who require strip-free testing due to occupation/job, especially to comply with DVLA guidelines for Group 2 and vocational drivers license holders)